3rd World Congress on Virology and Drug Development - 2025

INVITATION TO 3RD WORLD CONGRESS ON VIROLOGY AND DRUG DEVELOPMENT - 2025

Dear Colleagues and Friends,

On behalf of the scientific committee, it gives us immense pleasure to announce and cordially invite you all for the upcoming “3rd Edition of Virology and Drug Development - 2024” to be held in JNU CONVENTION CENTRE, New Delhi, India from 20th - 21st November, 2025. The International Summit has been organised around the theme of “Revolutionary Advancements in Virology and Drug Development” Thus it will mainly focus on latest advances and innovations in prevention, diagnosis and treatment of wide range of viral illnesses as well as the latest development in the arena of drug discovery and development.

The congress continues to provide a global forum with an interdisciplinary approach, featuring keynote talks, mini-plenary sessions, workshops, debates, expert review, posters and interactive discussions examining novel and exciting advancements in the management and treatment of a various emerging and re-emerging viral diseases. The conference will also focus on issues, clinical and medical challenges, and research studies that provide clinicians with essential information for choosing the most effective treatments and medications for patients with viral infections. In parallel the conference will also discuss on different topics from Drug Development ranging from Structural Biology, Drug Delivery & Targeting, Process Chemistry and Drug Manufacturing, Pulmonary Drug Discovery & Therapy, Innovative Drug Discovery and Nanotechnology, Pharmaceutical Biotechnology, Proteomics & Bioinformatics, Pharmacogenomics, Protein and Peptide Sciences, Drug Metabolism, Hot Topics in Medicinal Chemistry, Medical Imaging etc.

Moreover, the meeting will offer a superb platform for all Pharma & healthcare professionals to attend expert updates and to share and exchange best practices, knowledge and experiences in order to establish networking and collaborations among world-wide academic and clinical professionals.

We are certain that your participation or presentation at the conference will contribute significantly to its success.

We look forward to seeing you at the conference.

With Best Regards,

World Congress on Virology and Drug Development – 2025

Organizing Committee

Bangalore, Karnataka, India

Scientific Session

• Track 1: Basic Virology
• Track 2: Clinical Virology
• Track 3: Viral Pathogenesis
• Track 4: Viral Genomics and Bioinformatics
• Track 5: Viral Ecology and Evolution
• Track 6: Viral Vaccines and Immunology
• Track 7: Public Health and Epidemiology
• Track 8: Therapeutics and Antiviral Agents
• Track 9: Viral Diagnostics and Laboratory Techniques
• Track 10: One Health Approaches to Virology
• Track 11: Structural Biology
• Track 12: Pharmaceutical Research & Development
• Track 13: CNS Drug Discovery & Therapy
• Track 14 Pharmacogenomics
• Track 15: Protein and Peptide Sciences
• Track 16: Hot Topics in Medicinal Chemistry
• Track 17: Hot Topics in HIV Research
• Track 18: Combinatorial Chemistry
• Track 19: Hot Topics in Drug Targets
• Track 20: Hot Topics in Natural Products
• Track 21: Recent Advances in Spectroscopy
• Track 22: Pharmaceutical Biotechnology
• Track 23: Proteomics & Bioinformatics
• Track 24: In-silico Drug Design and in-silico screening
• Track 25: Stereoselective Synthesis of Bioactive Compounds

SUBMIT ABSTRACT

• Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.
• The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
• The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Any references should be noted as citations within the text and not as footnotes at the end

Important Dates

1st Abstract Submission Deadline: 17th March, 2025

Early Bird Registration Closes: 17th August, 2024

FOCUS OF THE CONFERENCE

The main objectives of the 3rd World Congress on Virology and Drug Development - 2025 are to bring together onsite the scientists and researchers, senior as well as early-stage, working in the field of Infectious Diseases and latest advancements in the fields of drug development also to build worthwhile or research relationships, and find international acquaintances for future alliance by face-to-face interactions.

• Explore insights on recent advancements, new equipment, new techniques, and unpublished data, learn from thought-leaders and get to network with a great line up of speakers.
• The main focus of "3rd World Congress on Virology and Drug Development - 2025” is on the recent advances across the spectrum of Virology and infectious diseases research from basic sciences to public health. Conference highlights will be Virology And its Evolution; Virus Structure and Classification; Corona Virus (COVID -19) ; Emerging and Re-emerging Infectious Diseases;Clinical and Neuro virology; Molecular virology; Pathology and Virulance (Host-Paasite Interaction);Herbal Medicine; Viral immunology; Retroviology; Viral Oncology; Veterinary Virology; Current Research in Virology; Mycology and Ecology; Medical and Clinical Mycology; Environmental and Applied Mycology; Veterinary Virology; Bacteriology, parasitology, fungal diseases, Vaccines and vaccination; Inflammation and Therapies; Food and Nutrition; Comorbidities and Infectious Diseases.
• Get to the heart of why formulation and delivery strategies fail. Dissect the challenges before looking for concrete solutions.
• Discover how advances in the sector are impacting both large and small molecule drugs.
• Discover the latest innovations in drug delivery devices.
• Be inspired by innovative case studies and realise the potential impact on your formulation or delivery processes.
• Engage in the exciting event format, with round tables, panels, showcases, speed networking and multiple conference tracks.
• Share experiences, insights and strategies in interactive peer-to peer round tables.
• Hear more perspectives in one place – from large medium and small organisations from pharma, biotech and academia.
• Discover how scientific formulation advancements are being implemented in practice.
• Understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set.
• Explore tried and tested routes to improve bioavailability.

• Virologists
• Virology Researchers
• Immunologists
• Microbiologists
• Epidemiologists
• Biochemists
• Biotechnologists
• Research scholars and scientists
• Viral Disease Researchers
• Biologists
• Universities and College Students
• Health Care Professionals
• Pharmaceutical and Healthcare Companies
• Medical colleges
• Life Science Students
• Research Labs
• Manufacturing and Medical Devices Companies
• Parasitology Students and Scientists
• Parasitology Researchers
• Veterinary Students
• Training Institutes
• Directors, CEO’s of Organizations
• Business Development Managers
• Chief Scientific Officers
• R&D Researchers from Biosimilar and Biologics Industries
• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Patent Attorneys
• Intellectual Property Attorneys
• Investment Analysts
• Association, Association presidents and professionals
• Drug development and discovery companies
• Formulation and Pharma Manufacturing companies
• Medical technology companies
• Universities and institutes
• Intellectual property and legal organizations
• Investors and financial services providers
• Bio-clusters and incubators
• Government and public support agencies
• Cosmetic companies
• Generic drugs and Biosimilars

HIGHLIGHTS OF THE CONFERENCE

• Join this conference to present your tremendous research outputs, listen from others and learn new methods to implement in your research
• Meet a range of specialists actively practicing in the field
• Explore different routes to improve bioavailability.
• Share experiences, insights and strategies in interactive peer-to peer round tables.
• Discover how scientific formulation advancements are being implemented in practice.
• Be inspired by innovative case studies